Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis.
Even in the absence of an adaptive immune system in murine models, lymphatic dilatation and dysfunction occur in filarial infections, although severe irreversible lymphedema and elephantiasis appears to require an intact adaptive immune response in human infections. To address how filarial parasites and their antigens influence the lymphatics directly, human lymphatic endothelial cells were exposed to filarial antigens, live parasites, or infected patient serum. Live filarial parasites or filarial antigens induced both significant LEC proliferation and differentiation into tube-like structures in vitro. Moreover, serum from patently infected (microfilaria positive) patients and those with longstanding chronic lymphatic obstruction induced significantly increased LEC proliferation compared to sera from uninfected individuals. Differentiation of LEC into tube-like networks was found to be associated with significantly increased levels of matrix metalloproteases and inhibition of their TIMP inhibitors (Tissue inhibitors of matrix metalloproteases). Comparison of global gene expression induced by live parasites in LEC to parasite-unexposed LEC demonstrated that filarial parasites altered the expression of those genes involved in cellular organization and development as well as those associated with junction adherence pathways that in turn decreased trans-endothelial transport as assessed by FITC-Dextran. The data suggest that filarial parasites directly induce lymphangiogenesis and lymphatic differentiation and provide insight into the mechanisms underlying the pathology seen in lymphatic filariasis.
Bennuru
Sasisekhar
S
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. bennurus@niaid.nih.gov
Nutman
Thomas B
TB
D002454:Cell Differentiation / Q000276:immunology; D049109:Cell Proliferation; D002469:Cell Separation; D004605:Elephantiasis, Filarial / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D042783:Endothelial Cells / Q000276:immunology / Q000469:parasitology* / Q000473:pathology*; D005434:Flow Cytometry; D015870:Gene Expression / Q000276:immunology; D006801:Humans; D042583:Lymphangiogenesis / Q000276:immunology*; D020781:Matrix Metalloproteinase 1 / Q000096:biosynthesis / Q000276:immunology; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis / Q000276:immunology; D018613:Microscopy, Confocal; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000096:biosynthesis / Q000276:immunology; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000096:biosynthesis / Q000276:immunology
D019715:Tissue Inhibitor of Metalloproteinase-1; D019716:Tissue Inhibitor of Metalloproteinase-2; D020778:Matrix Metalloproteinase 2; D020781:Matrix Metalloproteinase 1